Outcomes and User Acceptance of the IntelliVue Alarm Advisor Software (USA)
NCT ID: NCT03347149
Last Updated: 2018-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1336 participants
OBSERVATIONAL
2017-08-28
2018-03-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcomes and User Acceptance of the IntelliVue Alarm Advisor Software (Europe)
NCT03182452
Using Technical Filtering and Clinical Criteria to Reduce Vital Sign Alarms Using Continuous Monitoring in the Ward
NCT05171322
Telemonitoring in Home Mechanical Ventilation
NCT06143384
Automated Alerts of Patient Deterioration vs. Routine Monitoring of High-risk Patients Admitted to Medical Wards
NCT04661748
Setting up a Warehouse of Physiological Data and Biomedical Signals in Adult Intensive Care
NCT02893462
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In an interim period an Alarm Advisor software will be introduced to the unit. In a second phase (post-implementation) the same set of alarm data will be recorded.
The "Alarm Advisor" Software can identify alarms based on criteria set by the medical staff and provide hints to reduce alarms and alarm nuisance (e.g. by proposing adjustments of alarm limits).
The effect of reduction of recurring nuisance alarms through the implementation of the Alarm Advisor shall be evaluated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pre-Phase (Control)
no Alarm Advisor Software installed
No interventions assigned to this group
Post-Phase (Observation)
Alarm Advisor Software implemented
Alarm Advisor Software
Providing advice on alarm limits as part of routine medical care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Alarm Advisor Software
Providing advice on alarm limits as part of routine medical care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yale University
OTHER
Philips Healthcare
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marjorie Funk, PhD, Professor
Role: PRINCIPAL_INVESTIGATOR
Yale School of Nursing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale University
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PMS-BBN-US-AA-2.01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.